Stockreport

IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF Cryogenic flow control enhances the efficacy and precision of cryoablation proceduresRobust IP portfolio becomes increasingly strategic as global interest in IceCure's  [Read more]